Natera (NTRA) Stock Forecast & Price Target

$203.19 -0.50 (-0.25%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$203.46 +0.28 (+0.14%)

As of 05/22/2026 07:59 PM Eastern

Compare

Natera - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 19 Analyst Ratings

Sell
1

Hold
3

Buy
15

Based on 19 Wall Street analysts who have issued ratings for Natera in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 3 have given a hold rating, 14 have given a buy rating, and 1 has given a strong buy rating for NTRA.

Consensus Price Target

$256.60
26.29% Upside

According to the 19 analysts' twelve-month price targets for Natera, the average price target is $256.60. The highest price target for NTRA is $300.00, while the lowest price target for NTRA is $172.00. The average price target represents a forecasted upside of 26.29% from the current price of $203.19.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for NTRA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Natera and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NTRA Analyst Ratings Over Time

Type	Current Forecast 5/23/25 to 5/23/26	1 Month Ago 4/23/25 to 4/23/26	3 Months Ago 2/22/25 to 2/22/26	1 Year Ago 5/23/24 to 5/23/25
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	14 Buy rating(s)	14 Buy rating(s)	13 Buy rating(s)	16 Buy rating(s)
Hold	3 Hold rating(s)	3 Hold rating(s)	3 Hold rating(s)	0 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$256.60	$253.47	$249.20	$182.12
Forecasted Upside	26.29% Upside	26.02% Upside	17.48% Upside	18.78% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

NTRA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

NTRA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Natera Stock vs. The Competition

Type	Natera	Medical Companies	Broader Market
Consensus Rating Score	2.79	2.30	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	26.29% Upside	1,714.95% Upside	15.09% Upside
News Sentiment Rating	Positive News See Recent NTRA News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/12/2026	Piper Sandler 2 of 5 stars		Reiterated Rating	Overweight	$249.00	+25.04%
5/11/2026	BTIG Research 2 of 5 stars	Mark Massaro 1 of 5 stars	Lower Target	Buy	$260.00 ➝ $250.00	+24.85%
5/8/2026	Robert W. Baird 3 of 5 stars		Set Target		$265.00	+32.16%
5/8/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$270.00	+34.30%
5/8/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Casey Woodring Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$260.00 ➝ $265.00	+35.52%
5/8/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brandon Couillard Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$215.00 ➝ $220.00	+6.60%
4/21/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Sell (D-)
4/14/2026	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Brackmann Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Outperform
3/3/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tejas Savant Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$265.00 ➝ $250.00	+23.78%
1/12/2026	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kyle Mikson Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy
Get the Latest News and Ratings for NTRA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Natera and its competitors with MarketBeat's FREE daily newsletter.
1/7/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy
1/7/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Donnelly Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Buy	$300.00	+20.61%
1/5/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Subbu Nambi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$230.00 ➝ $270.00	+16.88%
1/1/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
12/15/2025	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Luke Sergott Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$230.00 ➝ $270.00	+16.40%
11/18/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Elizabeth Garcia Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$218.00 ➝ $280.00	+31.56%
11/13/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mason Carrico Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$197.00 ➝ $235.00	+13.46%
10/27/2025	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Navann Ty Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold	$172.00	-10.41%
9/2/2025	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Conor McNamara Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Outperform	$268.00	+58.26%
1/28/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Matthew Sykes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$160.00 ➝ $190.00	+15.02%
1/10/2025	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Eve Burstein Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$160.00 ➝ $200.00	+15.18%
11/13/2024	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$121.00 ➝ $157.00	-3.73%
10/17/2024	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Outperform	$140.00 ➝ $150.00	+19.53%
6/3/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Buy	$142.00	+33.30%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:20 PM ET.

NTRA Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Natera is $256.60, with a high forecast of $300.00 and a low forecast of $172.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Natera in the last year. There is currently 1 sell rating, 3 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NTRA shares.

According to analysts, Natera's stock has a predicted upside of 26.29% based on their 12-month stock forecasts.

Natera has been rated by research analysts at BTIG Research, Evercore, JPMorgan Chase & Co., Morgan Stanley, Piper Sandler, Robert W. Baird, Weiss Ratings, Wells Fargo & Company, and William Blair in the past 90 days.

Analysts like Natera more than other "medical" companies. The consensus rating for Natera is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how NTRA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Natera Recommendations

This page (NASDAQ:NTRA) was last updated on 5/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Natera (NTRA) Stock Forecast & Price Target